Blu Lotus Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 288.77%
- Ebitda 532.67%
- Net Worth 149.08%
- Total Assets 487.13%
About Blu Lotus Healthcare
Blu Lotus Healthcare Private Limited (BLHPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2018 (Six years and four months 15 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narayan Agarwal, Saurabh Agarwal, Prasann Mohnot, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909GJ2018PTC104150
-
Company No.
104150
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Blu Lotus Healthcare?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayan Agarwal
|
Director | 19-Sep-2018 | Current |
|
Saurabh Agarwal
|
Director | 19-Sep-2018 | Current |
|
Prasann Mohnot
|
Director | 19-Sep-2018 | Current |
|
Aashish Mohnot
|
Director | 19-Sep-2018 | Current |
Financial Performance of Blu Lotus Healthcare.
Blu Lotus Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 288.77% increase in profit. The company's net worth Soared by an impressive increase of 149.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blu Lotus Healthcare?
In 2023, Blu Lotus Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bangali Baba Foods Private LimitedNarayan Agarwal and Saurabh Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blu Lotus Healthcare?
Unlock and access historical data on people associated with Blu Lotus Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blu Lotus Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blu Lotus Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.